Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
244.59%Cost of Revenue Margin
VS
Market
Sector
Industry
History
$ 2.54Close
$ 1.18 - $ 11.68 52-Week Range
Ticker Information
Ticker
BTAICompany Name
BIOXCEL THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQBIOXCEL THERAPEUTICS INC - Cost of Revenue Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
BTAI - COGS % Historical data
| Date | Cost of Revenue | Cost of Revenue Margin | Revenues |
|---|---|---|---|
| 6/30/2025 | $ 2.12M | 244.59% | $ 868K |
| 3/31/2025 | $ 2.08M | 112.2% | $ 1.85M |
| 12/31/2024 | $ 2.14M | 94.57% | $ 2.27M |
| 9/30/2024 | $ 2.03M | 89.02% | $ 2.28M |
| 6/30/2024 | $ 1.37M | 56.93% | $ 2.4M |
| 3/31/2024 | $ 1.33M | 75.85% | $ 1.76M |
| 12/31/2023 | $ 1.26M | 91.3% | $ 1.38M |
| 9/30/2023 | $ 556K | 44.77% | $ 1.24M |
| 6/30/2023 | $ 55K | 5.3% | $ 1.04M |
| 3/31/2023 | $ 29K | 4.99% | $ 581K |
Key Performance Insights, Last 5 Years
- BIOXCEL THERAPEUTICS INC's latest trailing twelve months (TTM) COGS % stands at 0%.
- Over the past 5 years, BIOXCEL THERAPEUTICS INC's average COGS % has been 69.41%.
- The median COGS % for BIOXCEL THERAPEUTICS INC during this period was 66.39%
- BIOXCEL THERAPEUTICS INC reached its highest COGS % over the past 5 years at 244.59%.
- The lowest COGS % recorded by BIOXCEL THERAPEUTICS INC in the same timeframe 4.99%
BIOXCEL THERAPEUTICS INC's COGS % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
COGS % Benchmarks
Similar metrics to Revenues:
- Cost of Revenue - [Income Statement] The cost of revenue is the total amount paid to produce and sell a product or service and can be found in the income statement.
- Revenues - [Income Statement] The sum of revenue generated from all sold goods and rendered services.
- Interest Expense Margin - [Calculation] The company’s interest expenses [IntExp] expressed as a percentage of [Revenue].
- Operating Cash Flow Margin - [Calculation] The company's operating cash flow [NCFO] expressed as a percentage of [Revenue].
- Stock Based Compensation Margin - [Calculation] The company’s stock-based compensation [SbComp] expressed as a percentage of [Revenue].
Definition of Cost of Revenue Margin
[Calculation] The Cost of Revenue [CoR] expressed as a percentage of [Revenue]. Also named Cost Revenue Ratio.COGS / Revenues
(=) COGS % COGS % for BIOXCEL THERAPEUTICS INC is calculated as follows: COGS [ $ 0 ] / Revenues [ $ 0 ]
(=) COGS % [ 0% ] BTAI - Cost of Revenue Margin, Last 5 years
4.99%
Minimum
Mar 31, 2023
244.59%
Maximum
Jun 30, 2025
69.41%
Average
66.39%
Median
COGS % Benchmark AnalysisMarket
The chart above depicts the distribution of COGS % for companies in the Total Stock Market. The average COGS % of the companies is 46.87% with a standard deviation of 31.57%.
The following table provides additional summary stats:
COGS % in the Market:
| filtered constituents | 3.8K |
|---|---|
| min | -50.26% |
| max | 172.25% |
| average | 46.87% |
| median | 50.52% |
| std | 31.57% |